Cannabis stocks remain a high-risk, high-potential investment. To determine our picks for the best stocks, we considered companies trading in the U.S. and Canada with market caps over $300 million, ...
It's an unuaual company, in that it doesn't sell a single ounce of weed.
These companies are major players in the U.S. marijuana market, and they all generated more than $1 billion in revenue last year.
Zacks Investment Research on MSN
Should you buy CGC stock after marijuana reclassification?
Canopy Growth Corporation CGC is back in focus as marijuana reclassification efforts revive investor interest in cannabis ...
Canadian pot stocks are booming this week with some companies seeing their value rise by over 20 percent in one day, leaving some analysts worrying that investors are acting irrationally and creating ...
Cannabis stocks jumped on April 23 when the U.S. Department of Justice announced it was reclassifying cannabis from a Schedule I to a Schedule III drug. When the smoke cleared, however, and investors ...
Cannabis stocks and funds that hold them surged after the Trump administration moved it from the government most restrictive drug category to one that can be obtainable with a prescription.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results